Gossamer Bio Inc

Gossamer Bio Inc(GOSS)價格預測

$9.750

+0.341 (+3.50%)收盤時

價格預測

1-Day Price Prediction
-7.18%
1-Week Prediction
-5.98%
1-Month Prediction
—
2026 Prediction
—
2030 Prediction
—

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

GOSS 相似圖表分析預測

Alphio's GOSS stock price prediction model matches the current Gossamer Bio Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.05 (-7.18%). The 1-week path is $9.17 (-5.98%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 Gossamer Bio Inc 股票嗎?

Gossamer Bio Inc is currently not a strong buy due to its significant year-to-date decline of 95.77% and a recent earnings miss with an EPS of -16.80, which was 202.7% below expectations. However, the company has secured $250 million in financing for its drug development, which could positively impact future performance. The RSI is at 50.54, indicating a neutral momentum, and the stock is trading at $9.75, well below its 52-week high of $309.60, suggesting potential for recovery. The main risk is the high insider selling activity, which has increased by 535.94% over the last quarter, indicating a lack of confidence from insiders.

GOSS 股價於 Friday 收在 $9.75,此前上漲 +3.50%

Gossamer Bio Inc (GOSS) last closed at $9.75, gaining +3.50%. These facts feed the 1-day and 1-week GOSS price prediction above.

預測驅動因素

Gossamer Bio Inc(GOSS)的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Positive

Bullish

SMA 200

Negative

Bearish

相似圖表形態

近期走勢與 GOSS 最接近的股票,依相似度排序。

GOSS 季節性分析

Historically the probability of a positive November return for GOSS is 43.18%. March offers the highest probability of a positive month at 65.08%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易